1 depicts the early and persistent reduction in insulin and carbohydrate intake with semaglutide
The drugs help people produce insulin and lower the amount of sugar in the blood, which is why they help manage Type 2 diabetes
Bauer-Marinovic, M., Taugner, F., Florian, S
In pooled STEP trial data for semaglutide 2.4 mg: Nausea occurred in ~44% of participants Vomiting in ~24% Symptoms were most common during dose escalation Meals such as burgers, fried foods, and fast-food combinations are more likely to cause these symptoms than smaller, balanced meals
Form and frequency : Mounjaro is an injectable medication that you take once weekly
This is a lot more than the weight loss seen in others who took a placebo